- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0026784

Saarvik Pharmaceuticals Private Limited
About Saarvik Pharmaceuticals Private Limited
Data last updated:
Saarvik Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC348644. Its GSTIN is 09ABBCS9101R1ZS (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arvind Kumar Sharma and Suman Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.63 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹89,052 (net margin -4.8%) and EBITDA of -₹85,501 (EBITDA margin -4.6%).
Saarvik Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0026784).
Company details
Recognitions & Rankings of Saarvik Pharmaceuticals
Contact details
Saarvik Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Saarvik Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saarvik Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Saarvik Pharmaceuticals Private Limited, buy the company report.
Financials of Saarvik Pharmaceuticals Private Limited
FY 2025 filings availableSaarvik Pharmaceuticals Private Limited reported revenue of ₹18.63 Lakh (up 38% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹85,501 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹89,052 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.6% | ||||
| Net Profit Margin | -4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saarvik Pharmaceuticals Private Limited, buy the company report.
Board of directors of Saarvik Pharmaceuticals Private Limited
Saarvik Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Sharma | Director | 12 Apr 2019 | 7 Years 7 Months | Current |
| Suman Sharma | Director | 02 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Saarvik Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Humakind Pharmaceuticals Private Limited | ₹18.78 Lakh (FY 2025) | 32.0% | Basti, Uttar Pradesh, India | |||
| Els Pharmaceuticals Private Limited | ₹18.64 Lakh (FY 2025) | 65.0% | Chennai, Tamil Nadu, India | |||
| Saarvik Pharmaceuticals Private Limitedthis company | ₹18.63 Lakh (FY 2024) | -₹89,052 | -4.8% | 38.0% | Delhi, India | |
| Medworld Pharmaceuticals Private Limited | ₹18.56 Lakh (FY 2025) | -74.0% | Thane, Maharashtra, India |
To see the full peer comparison of Saarvik Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saarvik Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saarvik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saarvik Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABBCS9101R1ZS | Uttar Pradesh | Active | 12 Sep 2021 |
To see the full GST registrations and return filing status of Saarvik Pharmaceuticals Private Limited, buy the company report.
Recent activity
Saarvik Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Santosh Kumar Sharma ceased to be Director on 02 Dec 2021.
Frequently asked questions
Saarvik Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 12 April 2019 (7+ years old) and is registered under CIN U51909DL2019PTC348644.
Saarvik Pharmaceuticals has 2 current directors:
- Arvind Kumar Sharma - Director
- Suman Sharma - Director
The latest financial statements of Saarvik Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Saarvik Pharmaceuticals is 09ABBCS9101R1ZS, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Saarvik Pharmaceuticals is U51909DL2019PTC348644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saarvik Pharmaceuticals was incorporated on 12 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Saarvik Pharmaceuticals by revenue are Humakind Pharmaceuticals Private Limited, Els Pharmaceuticals Private Limited, Medworld Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Santosh Kumar Sharma ceased to be Director on 02 Dec 2021. Suman Sharma was appointed as Director on 02 Dec 2021. Arvind Kumar Sharma was appointed as Director on 12 Apr 2019.
Yes, Saarvik Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0026784).
The registered office of Saarvik Pharmaceuticals is at C – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053.
Saarvik Pharmaceuticals operates in the trading industry, in the specialty segment.

